Open AccessExplorative study on patient's perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis
Author(s) -
Hellings Peter W,
Dobbels Fabienne,
Denhaerynck Kris,
Piessens Mark,
Ceuppens Jan L,
De Geest Sabina
Publication year - 2012
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-2-9
Subject(s) - medicine , otorhinolaryngology , allergy , nasal spray , side effect (computer science) , dermatology , nasal administration , surgery , immunology , computer science , programming language
Background In spite of the high prevalence of allergic rhinitis (AR) and the evidence‐based guidelines for treatment, little is known about the patients’ perceived knowledge level, expectations, preferences for treatment, and fear for side effects of treatment for AR. This study aimed at gaining insight into these patient‐related factors. Methods This explorative cross‐sectional survey study included a convenience sample of 170 patients with rhinitis and clinical suspicion of allergy at the department of Otorhinolaryngology and Allergology. Patients’ perceived knowledge level, expectations, patient preferences, and fear of side effects of allergy treatment were collected via a self‐report questionnaire developed for the purpose of this study. Results 22% of all patients (38/170) reported to have knowledge about anti‐allergic treatment. 40% (55/170) of rhinitis patients expected to be cured by the prescribed treatment, whereas 43% (73/170) of patients expected suppression of allergic symptoms. Nasal spray was the preferred route of anti‐allergic drug administration in 30% (52/170) of patients, followed by oral treatment (24%; 42/170), combination therapy (16%; 30/170), and injection therapy (15%; 27/170). More patients would choose a combination treatment with step‐down approach (31%; 53/170) than mono‐therapy with a step‐up approach (20%; 34/170). Fear for side effects was reported mainly for nasal corticosteroids (48%; 81/170) and less for oral antihistamines (33%; 36/170), leucotriene antagonists (21%, 36/170) and immunotherapy (19%, 33/170). Conclusions Patients consulting for rhinitis have high expectations of anti‐allergic treatment, prefer a nasal spray above oral treatment, prefer combined treatment rather than monotherapy, and fear adverse events of anti‐allergic treatment.